| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SIENTRA INC | 2,199,012 | 55,151,000 | 25.03% | ||
| 2 | Proteon Therapeutics | 2,017,872 | 36,039,000 | 16.36% | ||
| 3 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 33,524,000 | 15.21% | ||
| 4 | AMARIN CORP PLC | 8,087,486 | 19,814,000 | 8.99% | ||
| 5 | LOMBARD MEDICAL INC | 3,473,452 | 15,110,000 | 6.86% | ||
| 6 | CEMPRA INC | 428,935 | 14,738,000 | 6.69% | ||
| 7 | Dicerna Pharmaceuticals | 945,757 | 13,184,000 | 5.98% | ||
| 8 | TOBIRA THERAPEUTICS INC | 589,244 | 10,159,000 | 4.61% | ||
| 9 | Innocoll | 555,555 | 7,950,000 | 3.61% | ||
| 10 | ZOGENIX INC | 291,902 | 3,923,000 | 1.78% | ||
| 11 | ANTHERA PHARMACEUTICALS I | 437,994 | 3,767,000 | 1.71% | ||
| 12 | REGULUS THERAPEUTICS INC | 327,350 | 3,588,000 | 1.63% | ||
| 13 | CHEMOCENTRYX INC | 215,000 | 1,769,000 | 0.80% | ||
| 14 | OncoGenex Pharmaceuticals Inc | 603,740 | 1,407,000 | 0.64% | ||
| 15 | FLEX PHARMA INC COM | 10,000 | 172,000 | 0.08% | ||
| 16 | Epirus Biopharma | 7,896 | 45,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-009063, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
